Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

KVUE – Kenvue Inc

KVUE — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

3.49

Margin Of Safety %

7

Put/Call OI Ratio

0.58

EPS Next Q Diff

0.04

EPS Last/This Y

0.37

EPS This/Next Y

0.07

Price

17.5

Target Price

19.3

Analyst Recom

3

Performance Q

1.04

Upside

-43.5%

Beta

0.55

Ticker: KVUE




5 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09KVUE18.160.580.30619467
2026-03-10KVUE17.950.580.82619154
2026-03-11KVUE17.650.580.55619920
2026-03-12KVUE17.370.580.22618871
2026-03-13KVUE17.390.580.22618871
DateSymbolLatestP/C OIP/C VolTotal OI
5 items Current Page1 of 1




5 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09KVUE18.168.7716.91.13
2026-03-10KVUE17.968.7720.81.13
2026-03-11KVUE17.678.7707.51.13
2026-03-12KVUE17.378.7708.41.13
2026-03-13KVUE17.508.7765.91.13
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
5 items Current Page1 of 1




6 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-06KVUE369.71-2.633.09
2026-03-09KVUE369.71-2.663.09
2026-03-10KVUE369.71-2.663.09
2026-03-11KVUE369.71-2.663.49
2026-03-12KVUE369.71-2.663.49
2026-03-13KVUE369.71-2.663.49
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
6 items Current Page1 of 1

Last Quarter Act. EPS

0.27

Avg. EPS Est. Current Quarter

0.26

Avg. EPS Est. Next Quarter

0.31

Insider Transactions

369.71

Institutional Transactions

-2.66

Beta

0.55

Average Sales Estimate Current Quarter

3845

Average Sales Estimate Next Quarter

3952

Fair Value

18.76

Quality Score

83

Growth Score

64

Sentiment Score

27

Actual DrawDown %

37

Max Drawdown 5-Year %

Target Price

19.3

P/E

22.91

Forward P/E

14.63

PEG

2.58

P/S

2.22

P/B

3.11

P/Free Cash Flow

19.48

EPS

0.76

Average EPS Est. Cur. Y​

1.13

EPS Next Y. (Est.)

1.2

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

9.72

Relative Volume

0.44

Return on Equity vs Sector %

-11.4

Return on Equity vs Industry %

-10.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

765.9
Kenvue Inc.
Sector: Consumer Defensive
Industry: Household & Personal Products
Employees: 21780
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
KVUE

Latest News

Caricamento notizie per KVUE
stock quote shares KVUE – Kenvue Inc Stock Price stock today
news today KVUE – Kenvue Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch KVUE – Kenvue Inc yahoo finance google finance
stock history KVUE – Kenvue Inc invest stock market
stock prices KVUE premarket after hours
ticker KVUE fair value insiders trading